Bayer Discontinued Essure — What’s Next for Lawsuits, Safety?

Bayer announced it would stop selling its Essure birth control device at the end of 2018. It’s the end of the device in the U.S., but it may only be the beginning of more controversy surrounding the implant.

Bayer insists its decision to discontinue Essure was a financial decision. It blames “misleading and inaccurate publicity”...

Bayer Discontinued Essure — What’s Next for Lawsuits, Safety? Continue reading…

Goshen nursing home’s troubles reflect larger for-profit trend

GOSHEN — Nurses picketed, state Department of Health inspectors swarmed, and complaints streamed to local elected leaders and the Times Herald-Record in the months after for-profit owners bought the former Elant nursing home in Goshen.

Now, nearly a year after the home became Sapphire Nursing and Rehab at Goshen, a Westchester law firm has filed...

Goshen nursing home’s troubles reflect larger for-profit trend Continue reading…

Monsanto Loses $289 Million Verdict in Roundup Cancer Trial

Monsanto Co. was socked with $289 million in damages in the first trial over claims that its Roundup weed killer causes cancer.

Lee Johnson, a former school groundskeeper whose doctors didn’t think he’d live long enough learn the verdict, prevailed Friday in San Francisco state court after jurors deliberated for three days. The trial was...

Monsanto Loses $289 Million Verdict in Roundup Cancer Trial Continue reading…

AstraZeneca to pay $110 million to settle US lawsuits related to Seroquel, Crestor

AstraZeneca agreed to pay $110 million to settle two lawsuits in the US claiming that the company fraudulently marketed Seroquel (quetiapine) and Crestor (rosuvastatin). "While we deny the allegations, it is in the best interests of the company to resolve these matters…while avoiding the delay, uncertainty and expense of protracted litigation," the drugmaker said....

AstraZeneca to pay $110 million to settle US lawsuits related to Seroquel, Crestor Continue reading…

Stale Cockpit Air May Be Dulling Your Airline Pilot’s Performance

That poorly ventilated conference room isn’t the only place with the potential for sick-air syndrome.

Airliner cockpits can also have levels of carbon dioxide elevated enough that in simulations it causes pilots to fail test maneuvers at higher rates than normal, a new Harvard University study has found.

The first-of-its-kind research suggests that current regulations aren’t...

Stale Cockpit Air May Be Dulling Your Airline Pilot’s Performance Continue reading…

Insys to pay $150 million to settle U.S. opioid kickback probe

(Reuters) - Insys Therapeutics said on Wednesday it had reached a deal to pay at least $150 million to resolve a U.S. Justice Department investigation into claims that the drugmaker paid doctors kickbacks to prescribe a powerful opioid medication.

Insys announced the tentative deal shortly before a former district sales manager pleaded guilty in a...

Insys to pay $150 million to settle U.S. opioid kickback probe Continue reading…

FDA expands recall of heart drug for possible cancer-causing contamination

A popular drug used to treat high blood pressure has been recalled because some products may contain a cancer-causing chemical.

In an ongoing investigation, the Food & Drug Administration has expanded the swath of the recall of the drug valsartan, which is used to treat high blood pressure and heart failure. The recalled drugs, manufactured...

FDA expands recall of heart drug for possible cancer-causing contamination Continue reading…

Wells Fargo faces tax credit probes, new problems with mortgage borrowers

NEW YORK (Reuters) - Wells Fargo & Co (WFC.N) is facing government probes into its use of low-income housing tax credits, and has also set aside $8 million to compensate borrowers who were incorrectly denied mortgage modifications under a federal assistance program, the bank said in a regulatory filing on Friday.

The new disclosures add...

Wells Fargo faces tax credit probes, new problems with mortgage borrowers Continue reading…

As rough-surface breast implants cause more lymphoma cases, critics decry continued use

In 2011, when the U.S. Food and Drug Administration first warned of a link between breast implants and a mysterious new cancer, it said the risk was vanishingly rare, far less than one in 500,000. Allergan, an implant maker, declared, “A woman is more likely to be struck by lightning than get this condition.”

Now,...

As rough-surface breast implants cause more lymphoma cases, critics decry continued use Continue reading…